China National Pharmaceutical Group Co Ltd (Sinopharm) actively implements the Healthy China 2030 initiative and is tasked with reforming the training and healthcare institutions of State organs. 

It has 50 health and wellness bases in more than 30 cities in 16 provinces, autonomous regions and municipalities across the country, which cover an area of about 1,800 hectares, have a floorage of 1 million square meters and provide more than 10,000 beds.

Their services extend to regions such as the Beijing-Tianjin-Hebei region, the Bohai Rim, the Yangtze River Delta, the Pearl River Delta and the Guangdong-Hong Kong-Macao Greater Bay Area.